The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification

Abstract Triple-negative breast cancer (TNBC) is widely recognized as the most aggressive form of breast cancer, occurring more frequently in younger patients and characterized by high heterogeneity, early distant metastases and poor prognosis. Multiple treatment options have failed to achieve the e...

Full description

Bibliographic Details
Main Authors: Lijuan Weng, Jianliang Zhou, Shenchao Guo, Nong Xu, Ruishuang Ma
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Cancer Cell International
Subjects:
Triple-negative breast cancer
Molecular subtyping
Precision medicine
Online Access:https://doi.org/10.1186/s12935-024-03261-0

Internet

https://doi.org/10.1186/s12935-024-03261-0

Similar Items